Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease

Nutr Metab Cardiovasc Dis. 2017 Sep;27(9):762-767. doi: 10.1016/j.numecd.2017.06.006. Epub 2017 Jun 15.

Abstract

Background and aim: Calcidiol (vitamin D metabolite) plasma levels vary with sun exposure (SE). However, it is not known if SE influences its prognostic ability. We have studied the effect of SE on plasma levels of the components of mineral metabolism (calcidiol, fibroblast growth factor-23 [FGF-23], parathormone [PTH], and phosphate [P]) and on their prognostic value in patients with coronary artery disease (CAD).

Methods and results: We studied prospectively 704 patients with stable CAD. Clinical variables and baseline calcidiol, FGF-23, PTH, and P plasma levels were assessed. We divided the population in two subgroups, according to the period of plasma extraction: High SE (HSE) (April-September) and low SE (LSE) (October-March). The outcome was the development of acute ischemic events (acute coronary syndrome, stroke, or transient ischemic attack), heart failure, or death. Mean follow-up was 2.15 ± 0.99 years. Calcidiol and P levels were higher in HSE group. In the whole population, calcidiol (HR = 0.84 for each 5 ng/ml increase, 95% CI = 0.71-0.99; p = 0.038) and FGF-23 (HR = 1.14 for each 100 RU/ml increase, 95% CI = 1.05-1.23; p = 0.009) were predictors of the outcome, along with age, hypertension, body-mass index, peripheral artery disease, and P levels. In the LSE subgroup, calcidiol (HR = 0.75; 95% CI = 0.57-0.99; p = 0.034) and FGF-23 (HR = 1.34; 95% CI = 1.13-1.58; p = 0.003) remained as predictors of the outcome. In the HSE group calcidiol and FGF-23 had not independent prognostic value.

Conclusions: In patients with stable CAD, low calcidiol and high FGF-23 plasma levels predict an adverse prognosis only when the sample is obtained during the months with LSE. SE should be taken into account in the clinical practice.

Keywords: FGF-23; Mineral metabolism; Stable coronary artery disease; Vitamin D.

Publication types

  • Multicenter Study

MeSH terms

  • Acute Coronary Syndrome / etiology
  • Acute Coronary Syndrome / mortality
  • Aged
  • Biomarkers / blood
  • Calcifediol / blood*
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / mortality
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / blood*
  • Heart Failure / etiology
  • Heart Failure / mortality
  • Humans
  • Ischemic Attack, Transient / etiology
  • Ischemic Attack, Transient / mortality
  • Male
  • Middle Aged
  • Parathyroid Hormone / blood
  • Phosphates / blood
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Risk Factors
  • Seasons*
  • Spain
  • Stroke / etiology
  • Stroke / mortality
  • Sunlight*
  • Time Factors

Substances

  • Biomarkers
  • FGF23 protein, human
  • PTH protein, human
  • Parathyroid Hormone
  • Phosphates
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Calcifediol